Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RxSight, Inc. Director's Dealing 2026

Mar 3, 2026

33077_dirs_2026-03-03_90e8a6fa-ea93-43e5-8c63-afe2ab362b8d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RxSight, Inc. (RXST)
CIK: 0001111485
Period of Report: 2026-02-28

Reporting Person: Wilterding Mark (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2026-02-28 Common Stock M 20441 Acquired 20441 Direct
2026-02-28 Common Stock F 8068 $7.61 Disposed 12373 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2026-02-28 Restricted Stock Unit $ M 20441 Disposed Common Stock (20441) Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F2: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one eighth (1/8th) of the shares subject to the RSU award vested on February 28, 2026, and one eighth (1/8th) of the shares subject to the RSU award will vest every six months thereafter on the last day of February and the last day of August over a four-year period.